CSM, a clinical trial supply company, plans to open a second cGMP facility in Malvern, Pennsylvania. The company has leased a 22,500-square-foot building to better serve its current and growing client base.
CSM has invested $1.5M to update the facility in order to meet cGMP standards. Once completed, the state-of-the-art facility will be fully equipped to handle a variety of clinical trial projects. Services offered at this facility will include temperature-controlled storage, both primary and secondary packaging and labeling, global distribution, label production, controlled substance storage, returns, and receiving.
“Our new Malvern facility and staff will be crucial in supporting the significant growth CSM anticipates over the next few years,” said Gerald Finken, CEO and President at CSM. “I am very excited that CSM will now have a physical presence on the East Coast, which will enable us to better deliver our quality, innovation, and personalized service to clients and patients around the globe.”
Staffing for the East Coast facility resulted from the acquisition of a global pharmaceutical company’s clinical supplies department, according to a press release. It is projected that this location will create additional jobs in the next three years.
Renovations will begin in April 2015, with an anticipated opening date of mid-year 2015. The new facility is located at 300 Technology Drive Malvern, PA. CSM’s headquarters will remain at 342 42nd St. S, Fargo, ND.
